Search

Search Results

• 

  Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center

  S. Casigliani Rabl, A. Della Rossa, P. Pepe, A. D'Ascanio, M. Mosca, A. Di Vita, S. Bombardieri

  158-165

  19-07-2012

  Published: 19 July 2012

  1036

  PDF: 803
• 

  MALDI-TOF and SELDI-TOF analysis: “tandem” techniques to identify potential biomarker in fibromyalgia

  C. Giacomelli, L. Bazzichi, L. Giusti, F. Ciregia, C. Baldini, Y. Da Valle, F. De Feo, F. Sernissi, A. Rossi, S. Bombardieri, A. Lucacchini

  165-170

  09-11-2011

  Published: 9 November 2011

  2208

  PDF: 1426
• 

  Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis

  M. Todoerti, W. Maglione, E. Bernero, A. Bortoluzzi, M. Colaci, E. Galuppi, S. Paolino, R. Talarico, M. Cutolo, C. Ferri, F. Trotta, S. Bombardieri, C.M. Montecucco, L. Sinigaglia

  207-218

  18-12-2013

  Published: 18 December 2013

  4341

  PDF: 2552
• 

  Treatment patterns of snti-TNF agents in Italy: an observational study

  L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

  18-28

  Published:

  1268

  PDF: 925
• 

  Adherence to cervical cancer screening in an Italian SLE cohort

  C. Tani, L. Carli, M. Mosca, C. Baldini, A. Consensi, M. Doveri, R. Talarico, S. Bombardieri

  11-17

  Published:

  1240

  PDF: 765
• 

  Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis

  L. Carli, C. Tani, S. Vagnani, F. Querci, C. Baldini, R. Talarico, A. Della Rossa, S. Bombardieri, M. Mosca

  203-204

  31-10-2013

  Published: 31 October 2013

  2604

  PDF: 660

  Appendix: 314
• 

  Fibromyalgia and sexual problems

  L. Bazzichi, C. Giacomelli, A. Rossi, F. Sernissi, P. Scarpellini, A. Consensi, S. Bombardieri

  261-267

  28-09-2012

  Published: 28 September 2012

  2707

  PDF: 1970

• Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes

  M. Fabris, L. Quartuccio, V. De Re, G. Pozzato, C. Mazzaro, A. Tavoni, C. Ferri, S. Salvin, A. Lerussi, C. Fabro, S. Bombardieri, S. De Vita

  28-34

  Published:

  1452

  PDF: 620

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  132-139

  Published:

  1885

  PDF: 1113

• Soluble P-selectin levels in synovial fluid and serum from patients with psoriatic arthritis

  R. Scrivo, A. Spadaro, V. Riccieri, M. Bombardieri, M. Di Franco, D. Celestino, G. Valesini

  250-255

  Published:

  984

  PDF: 669

• Italian consensus on EULAR recommendations 2005 for the management of hip osteoarthritis

  L. Punzi, M. Doherty, W. Zhang, M.A. Cimmino, M. Carrabba, L. Frizziero, W. Grassi, G. Lapadula, V. Modena, G. Arioli, O. Brignoli, B. Canesi, M. Cazzola, C. Cricelli, A. Faldini, A. Fioravanti, R. Gimigliano, A. Giustini, F. Iannone, G. Leardini, R. Meliconi, L. Molfetta, P. Patrignani, L. Parente, R. Ramonda, G. Randelli, F. Salaffi, A. Spadaro, S. Bombardieri

  301-309

  Published:

  2370

  PDF: 1213

• Churg-Strauss syndrome: outcome and long-term follow-up of 38 patients from a single Italian centre

  C. Baldini, A. Della Rossa, S. Grossi, E. Catarsi, R. Talarico, A. d'Ascanio, M. Mosca, R. Neri, A. Tavoni, S. Bombardieri

  118-124

  Published:

  1520

  PDF: 1471

• Pain patterns in italian patients with osteoarthritis: preliminary results of the MI.D.A. Study (Misurazione del Dolore nell’Artrosi)

  M.A. Cimmino, F. Salaffi, I. Olivieri, F. Trotta, P. Sarzi Puttini, W. Grassi, V. Modena, F.P. Cantatore, S. Bombardieri, S. Adami, L. Punzi, G. Lapadula, Gruppo MI.D.A.

  253-261

  Published:

  2287

  PDF: 6256

• Chronic inflammation and endothelial dysfunction: analysis of a cohort of patients with SLE and UCTD

  C. Tani, M. Mosca, A. d'Ascanio, D. Versari, A. Virdis, L. Ghiadoni, S. Taddei, A. Salvetti, S. Bombardieri

  212-218

  Published:

  1741

  PDF: 1290

• Ultrasound lung comets: new echographic sign of lung interstitial fibrosis in systemic sclerosis

  M. Doveri, F. Frassi, A. Consensi, E. Vesprini, L. Gargani, M. Tafuri, E. Picano, A. Della Rossa, A. Delle Sedie, A. d'Ascanio, C. Giacomelli, L. Bazzichi, S. Bombardieri

  180-184

  Published:

  1894

  PDF: 1992

• Neurological involvement in systemic sclerosis. Evidence of a central Raynaud’s phenomenon

  E. Di Poi, M. Bombardieri, R. Damato, E. Gremese, G. Valesini, GF. Ferraccioli

  289-297

  Published:

  898

  PDF: 720

• Antinflammatory therapy and cardiovascular risk: a consensus view

  D. Gatti, S. Adami, B. Canesi, M.A. Cimmino, O. Della Casa, M. Del Tacca, C. Klersy, G. Leardini, P. Patrignani, L. Punzi, S. Bombardieri

  85-93

  Published:

  1603

  PDF: 1085

• Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome

  N. Pugliese, M. Bruzzone, A. Della Rossa, C. Baldini, E. Catarsi, A. Tavoni, A. d'Ascanio, S. Bombardieri

  120-124

  Published:

  1148

  PDF: 1720

• Long term functional outcome of idiopathic inflammatory myopathies

  R. Neri, M. Mosca, T. Grazzini, A. Tavoni, G. Pasero, S. Bombardieri

  40-45

  Published:

  1032

  PDF: 938

• The registry for the systemic autoinflammatory syndromes of the Italian Society of Rheumatology

  Leonardo Punzi, Mauro Galeazzi, Vittorio Modena, Stefano Bombardieri

  1-4

  Published:

  681

  PDF: 1308

• The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet

  P. Sfriso, F. Salaffi, S. Bombardieri, B. Canesi, C.M. Montecucco, S. Todesco

  77-84

  Published:

  1766

  PDF: 811

• Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide

  C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri

  215-220

  Published:

  1162

  PDF: 782

• Differences in pharmacology of tumor necrosis factor (TNF) antagonists

  U. Fiocco, S. Bombardieri

  8-16

  Published:

  1112

  PDF: 1741

• Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)”

  M. Mosca, C. Tani, C. Neri, A. Della Rossa, C. Baldini, R. Talarico, L. Carli, S. Bombardieri

  35-40

  Published:

  1784

  PDF: 1514

• Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the “3E initiative”

  F. De Leonardis, S. Aliverini, E. Bonacci, A.M. Buono, S. Bombardieri, G.F. Ferraccioli, C. Montecucco, L. Sinigaglia, F. Trotta, G. Valentini

  34-45

  Published:

  1988

  PDF: 2223

• Primary Sjogren’s syndrome: clinical and serological feature of a single centre

  C. Baldini, A. Tavoni, G. Merlini, M. Sebastiani, S. Bombardieri

  256-261

  Published:

  1037

  PDF: 2992